» Articles » PMID: 37942005

Effects of Hepatic Mitochondrial Pyruvate Carrier Deficiency on Lipogenesis and Gluconeogenesis in Mice

Abstract

The liver coordinates the systemic response to nutrient deprivation and availability by producing glucose from gluconeogenesis during fasting and synthesizing lipids via lipogenesis (DNL) when carbohydrates are abundant. Mitochondrial pyruvate metabolism is thought to play important roles in both gluconeogenesis and DNL. We examined the effects of hepatocyte-specific mitochondrial pyruvate carrier (MPC) deletion on the fasting-refeeding response. Rates of DNL during refeeding were impaired by hepatocyte MPC deletion, but this did not reduce intrahepatic lipid content. During fasting, glycerol is converted to glucose by two pathways; a direct cytosolic pathway and an indirect mitochondrial pathway requiring the MPC. Hepatocyte MPC deletion reduced the incorporation of C-glycerol into TCA cycle metabolites, but not into new glucose. Furthermore, suppression of glycerol and alanine metabolism did not affect glucose concentrations in fasted hepatocyte-specific MPC-deficient mice, suggesting multiple layers of redundancy in glycemic control in mice.

Citing Articles

Sex-dependent adipose glucose partitioning by the mitochondrial pyruvate carrier.

Shannon C, Bakewell T, Fourcaudot M, Ayala I, Romero G, Asmis M bioRxiv. 2024; .

PMID: 38798427 PMC: 11118482. DOI: 10.1101/2024.05.11.593540.


Hepatic malonyl-CoA synthesis restrains gluconeogenesis by suppressing fat oxidation, pyruvate carboxylation, and amino acid availability.

Deja S, Fletcher J, Kim C, Kucejova B, Fu X, Mizerska M Cell Metab. 2024; 36(5):1088-1104.e12.

PMID: 38447582 PMC: 11081827. DOI: 10.1016/j.cmet.2024.02.004.


Disruption of hepatic mitochondrial pyruvate and amino acid metabolism impairs gluconeogenesis and endurance exercise capacity in mice.

Martino M, Habibi M, Ferguson D, Brookheart R, Thyfault J, Meyer G Am J Physiol Endocrinol Metab. 2024; 326(4):E515-E527.

PMID: 38353639 PMC: 11193532. DOI: 10.1152/ajpendo.00258.2023.


Disruption of Hepatic Mitochondrial Pyruvate and Amino Acid Metabolism Impairs Gluconeogenesis and Endurance Exercise Capacity in Mice.

Martino M, Habibi M, Ferguson D, Brookheart R, Thyfault J, Meyer G bioRxiv. 2023; .

PMID: 37662392 PMC: 10473655. DOI: 10.1101/2023.08.22.554345.

References
1.
Simons P, Valkenburg O, Stehouwer C, Brouwers M . Association between de novo lipogenesis susceptibility genes and coronary artery disease. Nutr Metab Cardiovasc Dis. 2022; 32(12):2883-2889. DOI: 10.1016/j.numecd.2022.09.003. View

2.
Deja S, Fu X, Fletcher J, Kucejova B, Browning J, Young J . Simultaneous tracers and a unified model of positional and mass isotopomers for quantification of metabolic flux in liver. Metab Eng. 2020; 59:1-14. PMC: 7108978. DOI: 10.1016/j.ymben.2019.12.005. View

3.
McCommis K, Kovacs A, Weinheimer C, Shew T, Koves T, Ilkayeva O . Nutritional modulation of heart failure in mitochondrial pyruvate carrier-deficient mice. Nat Metab. 2020; 2(11):1232-1247. PMC: 7957960. DOI: 10.1038/s42255-020-00296-1. View

4.
Snaebjornsson M, Janaki-Raman S, Schulze A . Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer. Cell Metab. 2019; 31(1):62-76. DOI: 10.1016/j.cmet.2019.11.010. View

5.
Chakravarthy M, Pan Z, Zhu Y, Tordjman K, Schneider J, Coleman T . "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab. 2005; 1(5):309-22. DOI: 10.1016/j.cmet.2005.04.002. View